UNSPSC 51112801: Droloxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C26H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0M67U6Z98F, chemically known as phenol, 3-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, (e)- but more generally known as droloxifene, which bears US NIH Compound Identifier 3033767. European Medicines Agency schedules Droloxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06405MIG.

UNSPSC 51112801 Droloxifene, a Commodity code, identifies a selective estrogen receptor modulator (SERM) pharmaceutical used in hormone-replacement and bone-density therapies. State and local governments procure droloxifene primarily through public health departments, correctional health systems, and institutional healthcare providers (hospitals, clinics, long-term care facilities) as part of formulary drug inventories and inmate or patient treatment regimens. Purchasing typically occurs via standing contracts with pharmaceutical wholesalers or direct agreements with manufacturers, often leveraging cooperative purchasing vehicles or state pharmacy benefit manager frameworks to negotiate volume pricing. The issuing bodies acquiring this drug span state departments of health, state corrections departments, county health systems, municipal hospitals, and regional healthcare authorities.

The source provided contains no recent state or local contract opportunities tagged to this code and no geographic activity data. Without posted solicitations, RFPs, RFQs, or awarded contracts in the recent-opportunities block, activity under this Commodity code cannot be characterized by jurisdiction, region, or representative procurement action. Firms tracking this code should monitor state health department formulary updates, state corrections procurement notices, and cooperative purchasing catalogs (such as regional or statewide healthcare purchasing alliances) to identify when droloxifene supply contracts or price agreements come to market.